Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Health and Me on MSN
Can CRISPR cure HIV? Scientists say virus removed from cells in new research
Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells ...
The chemokine receptors CCR5 and CXCR4 are the two major coreceptors for HIV entry. Numerous efforts have been made to develop a new class of anti-HIV agents that target these coreceptors as an ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...
Scientists have identified what they are calling an "Achilles heel" of the HIV/AIDS virus that may aid in developing a functional vaccine. Using complex mathematics that are also used in stock market ...
On January 6, 2026, OncoNano Medicine announced a research collaboration with Gilead Sciences to test its ON-BOARD ...
The clearance rates for those coinfected with HIV and hepatitis C virus (HCV) are still higher than those with HCV alone. Direct-acting antivirals (DAAs) are a means of curing HCV with an efficacy of ...
In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful. Today, ...
Monitor on MSNOpinion
Govt should ensure access to new HIV drug
The government should also encourage the private sector to import this drug so that Ugandans who can afford, should buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback